Imaflex Stock Price To Sales
IFX Stock | CAD 1.49 0.02 1.36% |
Imaflex fundamentals help investors to digest information that contributes to Imaflex's financial success or failures. It also enables traders to predict the movement of Imaflex Stock. The fundamental analysis module provides a way to measure Imaflex's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Imaflex stock.
Last Reported | Projected for Next Year | ||
Price To Sales Ratio | 0.49 | 0.47 |
Imaflex | Price To Sales |
Imaflex Company Price To Sales Analysis
Imaflex's Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Current Imaflex Price To Sales | 0.75 X |
Most of Imaflex's fundamental indicators, such as Price To Sales, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Imaflex is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Imaflex Price To Sales Driver Correlations
Understanding the fundamental principles of building solid financial models for Imaflex is extremely important. It helps to project a fair market value of Imaflex Stock properly, considering its historical fundamentals such as Price To Sales. Since Imaflex's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Imaflex's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Imaflex's interrelated accounts and indicators.
Click cells to compare fundamentals
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
Competition |
Imaflex Price To Sales Ratio
Price To Sales Ratio |
|
Based on the latest financial disclosure, Imaflex has a Price To Sales of 0.75 times. This is 98.82% lower than that of the Containers & Packaging sector and 68.35% lower than that of the Materials industry. The price to sales for all Canada stocks is 93.43% higher than that of the company.
Imaflex Price To Sales Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Imaflex's direct or indirect competition against its Price To Sales to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Imaflex could also be used in its relative valuation, which is a method of valuing Imaflex by comparing valuation metrics of similar companies.Imaflex is currently under evaluation in price to sales category among its peers.
Imaflex Current Valuation Drivers
We derive many important indicators used in calculating different scores of Imaflex from analyzing Imaflex's financial statements. These drivers represent accounts that assess Imaflex's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Imaflex's important valuation drivers and their relationship over time.
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Market Cap | 32.5M | 52.0M | 61.3M | 79.1M | 46.2M | 48.5M | |
Enterprise Value | 48.9M | 58.6M | 62.4M | 79.6M | 56.8M | 59.6M |
Imaflex Fundamentals
Return On Equity | 0.0749 | ||||
Return On Asset | 0.051 | ||||
Profit Margin | 0.04 % | ||||
Operating Margin | 0.14 % | ||||
Current Valuation | 86.36 M | ||||
Shares Outstanding | 52.09 M | ||||
Shares Owned By Insiders | 44.78 % | ||||
Shares Owned By Institutions | 10.16 % | ||||
Number Of Shares Shorted | 4.37 K | ||||
Price To Earning | 11.04 X | ||||
Price To Book | 1.23 X | ||||
Price To Sales | 0.75 X | ||||
Revenue | 93.59 M | ||||
Gross Profit | 18.05 M | ||||
EBITDA | 7.57 M | ||||
Net Income | 508.78 K | ||||
Cash And Equivalents | 328 K | ||||
Cash Per Share | 0.01 X | ||||
Total Debt | 11.41 M | ||||
Debt To Equity | 60.90 % | ||||
Current Ratio | 1.58 X | ||||
Book Value Per Share | 1.18 X | ||||
Cash Flow From Operations | 4.88 M | ||||
Short Ratio | 0.44 X | ||||
Earnings Per Share | 0.08 X | ||||
Target Price | 1.95 | ||||
Number Of Employees | 268 | ||||
Beta | 0.34 | ||||
Market Capitalization | 76.05 M | ||||
Total Asset | 83.48 M | ||||
Retained Earnings | 39.93 M | ||||
Working Capital | 13.99 M | ||||
Net Asset | 83.48 M |
About Imaflex Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Imaflex's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Imaflex using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Imaflex based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Imaflex Stock Analysis
When running Imaflex's price analysis, check to measure Imaflex's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Imaflex is operating at the current time. Most of Imaflex's value examination focuses on studying past and present price action to predict the probability of Imaflex's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Imaflex's price. Additionally, you may evaluate how the addition of Imaflex to your portfolios can decrease your overall portfolio volatility.